Skip to main content

Table 6 Comparison between the three groups according to hospital outcome and postoperative complications

From: Cardioprotective effect of propofol in cardioplegia compared to systemic propofol in heart valves surgery; a randomized controlled trial

Hospital outcome

Group 1 (n = 50)

Group 2 (n = 50)

Group 3 (n = 50)

P

Duration of Ventilation (hrs.)

11.04 ± 7.62

11.72 ± 7.59

15.86 ± 9.63

0.002*

Significance between groups

p1 = 0.033*, p2 = 0.972, p3 = 0.036*

ICU days

5.04 ± 1.35

3.42 ± 1.34

4.54 ± 1.13

 < 0.001*

Significance between groups

p1 < 0.001*, p2 = 0.161, p3 < 0.001*

Hospital days

11.02 ± 2.43

8.04 ± 2.21

12.26 ± 2.38

 < 0.001*

Significance between groups

p1 < 0.001*, p2 = 0.016*, p3 < 0.001*

Postoperative complications

 Pericardial tamponade

2 (4%)

1 (2%)

0 (0%)

MCp = 0.773

 Reintubation

1 (2%)

2 (4%)

3 (6%)

MCp = 0.872

 Arrythmias

14 (28%)

10 (20%)

6 (12%)

0.873

  1. Data are presented as mean ± SD. or frequency (percentage). ICU: intensive care unit. p1: p value for comparing between group1 and group2, p2: p value for comparing between group1 and group3, p3: p value for comparing between group2 and group3. * p < 0.05 is statistically significant
  2. Group 1: Patients with propofol in the cardioplegia, Group 2: Patients with propofol injection in the aortic line, Group 3 (control group): Patients without propofol in the cardioplegia or aortic line